Hims & Hers Health IncHIMS
Price$29.30Intrinsic value$12.6157% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.6B+74.6% YoYTTM through 30 Jun 2026
Net Income -$142M-212.7% YoYTTM through 30 Jun 2026
Free Cash Flow $61.7MTTM through 30 Jun 2026

Margins

Current
Gross Margin65.3%
EBITDA Margin-2.6%
Operating Margin-12.9%
Net Margin-5.5%

Returns

-20.6%ROE
-4.1%ROA

Balance Sheet Health

Debt / Equity2.18x
Current Ratio1.85x
Net Debt$223.2M
Cash & Equivalents$609.8M

Quality Metrics

Altman Z-Score1.71
Piotroski F-Score4 / 9
FCF Margin2.4%
Rule of 4026.7
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $2.3B
Diluted EPS-$0.64TTM
'19'20'21'22'23'24'25
FY2025: $0.50

Dividend

No dividend

Capital Allocation

Capex Intensity7.8%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.